Εμφανίζονται 1 - 20 Αποτελέσματα από 43 για την αναζήτηση '"РАБДОМИОСАРКОМА"', χρόνος αναζήτησης: 0,87δλ Περιορισμός αποτελεσμάτων
  1. 1
  2. 2
    Academic Journal

    Πηγή: Сборник статей

    Περιγραφή αρχείου: application/pdf

    Relation: Актуальные вопросы современной медицинской науки и здравоохранения: сборник статей VIII Международной научно-практической конференции молодых учёных и студентов, Екатеринбург, 19-20 апреля 2023 г.; http://elib.usma.ru/handle/usma/14155

    Διαθεσιμότητα: http://elib.usma.ru/handle/usma/14155

  3. 3
    Academic Journal

    Πηγή: Сборник статей

    Περιγραφή αρχείου: application/pdf

    Relation: Актуальные вопросы современной медицинской науки и здравоохранения: сборник статей VIII Международной научно-практической конференции молодых учёных и студентов, Екатеринбург, 19-20 апреля 2023 г.; http://elib.usma.ru/handle/usma/14143

    Διαθεσιμότητα: http://elib.usma.ru/handle/usma/14143

  4. 4
    Academic Journal

    Πηγή: Head and Neck Tumors (HNT); Том 12, № 4 (2022); 91-101 ; Опухоли головы и шеи; Том 12, № 4 (2022); 91-101 ; 2411-4634 ; 2222-1468 ; 10.17650/2222-1468-2022-12-4

    Περιγραφή αρχείου: application/pdf

    Relation: https://ogsh.abvpress.ru/jour/article/view/848/562; Sultan I., Qaddoumi I., Yaser S. et al. Comparing adult and pediatric rhabdomyosarcoma in the surveillance, epidemiology and end results program, 1973 to 2005: an analysis of 2, 600 patients. J Clin Oncol 2009;27(20):3391–7. DOI:10.1200/JCO.2008.19.7483; Ognjanovic S., Linabery A.M., Charbonneau B. et al. Trends in childhood rhabdomyosarcoma incidence and survival in the United States, 1975–2005. Cancer 2009;115(18):4218–26. DOI:10.1002/cncr.24465; Pappo A.S., Shapiro D.N., Crist W.M. Rhabdomyosarcoma. Biology and treatment. Pediatr Clin North Am 1997;44(4):953–72. DOI:10.1016/S0031-3955(05)70539-3; Шарлай А.С., Ботиралиева Г.K., Друй А.Е. и др. Распространенность аномалий гена FOXO1 в группе круглоклеточных рабдомиосарком с альвеолярной морфологией. Вопросы гематологии/онкологии и иммунопатологии в педиатрии 2020;19(4):82–7. DOI:10.24287/1726-1708-2020-19-4-82-87; Thway K., Wang J., Wren D. et al. The comparative utility of fluorescence in situ hybridization and reverse transcription-polymerase chain reaction in the diagnosis of alveolar rhabdomyosarcoma. Virchows Arch 2015;467(2):217–24. DOI:10.1007/s00428-015-1777-9; Rudzinski E.R., Anderson J.R., Chi Y.Y. et al. Histology, fusion status, and outcome in metastatic rhabdomyosarcoma: a report from the Children’s Oncology Group. Pediatr Blood Cancer 2017;64(12):10.1002/pbc.26645. DOI:10.1002/pbc.26645; Dagher R., Helman L. Rhabdomyosarcoma: an overview. Oncologist 1999;4:34–44.; Enzinger F.M., Shiraki M. Alveolar rhabdomyosarcoma. An analysis of 110 cases. Cancer 1969;24(1):18–31. DOI:10.1002/1097-0142(196907)24:13.0.CO;2-5; Maurer H.M., Gehan E.A., Beltangady M. et al. The Intergroup Rhabdomyosarcoma Study-II. Cancer 1993;71(5):1904–22. DOI:10.1002/1097-0142(19930301)71:53.0.co;2-x; Crist W., Gehan E.A., Ragab A.H. et al. The Third Intergroup Rhabdomyosarcoma Study. J Clin Oncol 1995;13(3):610–30. DOI:10.1200/JCO.1995.13.3.610; Jha P., Frölich A.M.J. Unusual association of alveolar rhabdomyosarcoma with pancreatic metastasis: emerging role of PET-CT in tumor staging. Pediatr Radiol 2010;40(8):1380–6. DOI:10.1007/s00247-010-1572-3; Khalbuss W.E., Gherson J., Zaman M. Pancreatic metastasis of cardiac rhabdomyosarcoma diagnosed by fine needle aspiration. A case report. Acta Cytol 1999;43(3):447–51. DOI:10.1159/000331098; Scott J., Cowell J., Robertson M.E. et al. Insulin-like growth factor-II gene expression in Wilms’ tumour and embryonic tissues. Nature 1985;317(6034):260–2. DOI:10.1038/317260a0; El-Badry O.M., Minniti C., Kohn E.C. et al. Insulin-like growth factor II acts as an autocrine growth and motility factor in human rhabdomyosarcoma tumors. Cell Growth Differ 1990;1(7):325–31.; McCarville M.B., Christie R., Daw N.C. et al. PET/CT in the evaluation of childhood sarcomas. AJR 2005;184(4): 1293–304. DOI:10.2214/ajr.184.4.01841293; Norman G., Fayter D., Lewis-Light K. et al. An emerging evidence base for PET-CT in the management of childhood rhabdomyosarcoma: systematic review. BMJ Open 2015;5(1):e006030. DOI:10.1136/bmjopen-2014-006030; Tateishi U., Hosono A., Makimoto A. et al. Comparative study of FDG PET/CT and conventional imaging in the staging of rhabdomyosarcoma. Ann Nucl Med 2009;23(2):155–61. DOI:10.1007/s12149-008-0219-z; Volker T., Denecke T., Steffen I. et al. Positron emission tomography for staging of pediatric sarcoma patients: results of a prospective multicenter trial. J Clin Oncol 2007;25(34):5435–41. DOI:10.1200/JCO.2007.12.2473; Kleis M., Daldrup-Link H., Matthay K. et al. Diagnostic value of PET/ CT for the staging and restaging of pediatric tumors. Eur J Nucl Med Mol Imaging 2009;36(1):23–36. DOI:10.1007/s00259-008-0911-1; Ayalon D., Glasser T., Werner H. Transcriptional regulation of IGF-I receptor gene expression by the PAX3-FKHR oncoprotein. Growth Horm IGF Res 2001;11(5):289–97. DOI:10.1054/ghir.2001.0244; https://ogsh.abvpress.ru/jour/article/view/848

  5. 5
    Academic Journal

    Πηγή: Russian Journal of Pediatric Hematology and Oncology; Том 10, № 3 (2023); 89-100 ; Российский журнал детской гематологии и онкологии (РЖДГиО); Том 10, № 3 (2023); 89-100 ; 2413-5496 ; 2311-1267

    Περιγραφή αρχείου: application/pdf

    Relation: https://journal.nodgo.org/jour/article/view/967/851; Jackson S.P., Bartek J. The DNA-damage response in human biology and disease. Nature. 2009;461(7267):1071–8. doi:10.1038/nature08467.; Khanna K.K., Jackson S.P. DNA double-strand breaks: signaling, repair and the cancer connection. Nat Genet. 2001;27(3):247–54. doi:10.1038/85798.; Hsieh P. Molecular mechanisms of DNA mismatch repair. Mutat Res. 2001;486(2):71–87. doi:10.1016/s0921-8777(01)00088-x.; Pardo B., Gómez-González B., Aguilera A. DNA repair in mammalian cells: DNA double-strand break repair: how to fix a broken relationship. Cell Mol Life Sci. 2009;66(6):1039–56. doi:10.1007/s00018-009-8740-3.; D’Andrea A.D. DNA Repair Pathways and Human Cancer. The Molecular Basis of Cancer: 4th Edition, 2014. Pp. 47–66.e2. doi:10.1016/B978-1-4557-4066-6.00004-4.; Hause R.J., Pritchard C.C., Shendure J., Salipante S.J. Classification and characterization of microsatellite instability across 18 cancer types. Nat Med. 2016;22(11):1342–50. doi:10.1038/nm.4191.; Chang S.C., Lan Y.T., Lin P.C., Yang S.H., Lin C.H., Liang W.Y., Chen W.S., Jiang J.K., Lin J.K. Patterns of germline and somatic mutations in 16 genes associated with mismatch repair function or containing tandem repeat sequences. Cancer Med. 2020;9(2):476–86. doi:10.1002/cam4.2702.; Tamura K., Kaneda M., Futagawa M., Takeshita M., Kim S., Nakama M., Kawashita N., Tatsumi-Miyajima J. Genetic and genomic basis of the mismatch repair system involved in Lynch syndrome. Int J Clin Oncol. 2019;24(9):999–1011. doi:10.1007/s10147-019-01494-y.; Boland P.M., Yurgelun M.B., Boland C.R. Recent progress in Lynch syndrome and other familial colorectal cancer syndromes. CA Cancer J Clin. 2018;68(3):217–31. doi:10.3322/caac.21448.; Adam R., Spier I., Zhao B., Kloth M., Marquez J., Hinrichsen I., Kirfel J., Tafazzoli A., Horpaopan S., Uhlhaas S., Stienen D., Friedrichs N., Altmüller J., Laner A., Holzapfel S., Peters S., Kayser K., Thiele H., Holinski-Feder E., Marra G., Kristiansen G., Nöthen M.M., Büttner R., Möslein G., Betz R.C., Brieger A., Lifton R.P., Aretz S. Exome Sequencing Identifies Biallelic MSH3 Germline Mutations as a Recessive Subtype of Colorectal Adenomatous Polyposis. Am J Hum Genet. 2016;99(2):337–51. doi:10.1016/j.ajhg.2016.06.015.; Lynch H.T., Lynch P.M., Pester J., Fusaro R.M. The cancer family syndrome. Rare cutaneous phenotypic linkage of Torre’s syndrome. Arch Intern Med. 1981;141(5):607–11. PMID: 7224741.; Barana D., van der Klift H., Wijnen J., Longa E.D., Radice P., Cetto G.L., Fodde R., Oliani C. Spectrum of genetic alterations in Muir–Torre syndrome is the same as in HNPCC. Am J Med Genet A. 2004;125A(3):318–9. doi:10.1002/ajmg.a.20523.; Bakry D., Aronson M., Durno C., Rimawi H., Farah R., Alharbi Q.K., Alharbi M., Shamvil A., Ben-Shachar S., Mistry M., Constantini S., Dvir R., Qaddoumi I., Gallinger S., Lerner-Ellis J., Pollett A., Stephens D., Kelies S., Chao E., Malkin D., Bouffet E., Hawkins C., Tabori U. Genetic and clinical determinants of constitutional mismatch repair deficiency syndrome: report from the constitutional mismatch repair deficiency consortium. Eur J Cancer. 2014;50(5):987–96. doi:10.1016/j.ejca.2013.12.005.; Suerink M., Wimmer K., Brugieres L., Colas C., Gallon R., Ripperger T., Benusiglio P.R., Bleiker E.M.A., Ghorbanoghli Z., Goldberg Y., Hardwick J.C.H., Kloor M., le Mentec M., Muleris M., Pineda M., Ruiz-Ponte C., Vasen H.F.A. Report of the fifth meeting of the European Consortium “Care for CMMRD” (C4CMMRD), Leiden, The Netherlands, July 6th 2019. Fam Cancer. 2021;20(1):67–73. doi:10.1007/s10689-020-00194-1.; Tabori U., Hansford J.R., Achatz M.I., Kratz C.P., Plon S.E., Frebourg T., Brugières L. Clinical Management and Tumor Surveillance Recommendations of Inherited Mismatch Repair Deficiency in Childhood. Clin Cancer Res. 2017;23(11):e32–e37. doi:10.1158/1078-0432.CCR-17-0574.; Martin-Giacalone B.A., Weinstein P.A., Plon S.E., Lupo P.J. Pediatric Rhabdomyosarcoma: Epidemiology and Genetic Susceptibility. J Clin Med. 2021;10(9):2028. doi:10.3390/jcm10092028.; Silva F.C., Valentin M.D., Ferreira F.O., Carraro D.M., Rossi B.M. Mismatch repair genes in Lynch syndrome: a review. Sao Paulo Med J. 2009;127(1):46–51. doi:10.1590/s1516-31802009000100010.; Wimmer K., Kratz C.P., Vasen H.F., Caron O., Colas C., Entz-Werle N., Gerdes A.M., Goldberg Y., Ilencikova D., Muleris M., Duval A., Lavoine N., Ruiz-Ponte C., Slavc I., Burkhardt B., Brugieres L.; EU-Consortium Cafe for CMMRD (C4CMMRD). Diagnostic criteria for constitutional mismatch repair deficiency syndrome: suggestions of the European consortium “cafe for CMMRD” (C4CMMRD). J Med Genet. 2014;51(6):355–65. doi:10.1136/jmedgenet-2014-102284.; Bailly C. Topoisomerase I poisons and suppressors as anticancer drugs. Curr Med Chem. 2000;7(1):39–58. doi:10.2174/0929867003375489.; Nitiss J.L. Targeting DNA topoisomerase II in cancer chemotherapy. Nat Rev Cancer. 2009;9(5):338–50. doi:10.1038/nrc2607.; Aronson M., Colas C., Shuen A., Hampel H., Foulkes W.D., Baris Feldman H., Goldberg Y., Muleris M., Wolfe Schneider K., McGee R.B., Jasperson K., Rangaswami A., Brugieres L., Tabori U. Diagnostic criteria for constitutional mismatch repair deficiency (CMMRD): recommendations from the international consensus working group. J Med Genet. 2022;59(4):318–27. doi:10.1136/jmedgenet-2020-107627.; Cronin M., Ross J.S. Comprehensive next-generation cancer genome sequencing in the era of targeted therapy and personalized oncology. Biomark Med. 2011;5(3):293–305. doi:10.2217/bmm.11.37.; Rizzo J.M., Buck M.J. Key principles and clinical applications of “next-generation” DNA sequencing. Cancer Prev Res (Phila). 2012;5(7):887–900. doi:10.1158/1940-6207.CAPR-11-0432.; Kratz C.P., Holter S., Etzler J., Lauten M., Pollett A., Niemeyer C.M., Gallinger S., Wimmer K. Rhabdomyosarcoma in patients with constitutional mismatch-repair-deficiency syndrome. J Med Genet. 2009;46(6):418–20. doi:10.1136/jmg.2008.064212.; https://journal.nodgo.org/jour/article/view/967

  6. 6
    Academic Journal

    Συνεισφορές: The study was performed without external funding, Исследование проведено без спонсорской поддержки

    Πηγή: Russian Journal of Pediatric Hematology and Oncology; Том 9, № 4 (2022); 96-101 ; Российский журнал детской гематологии и онкологии (РЖДГиО); Том 9, № 4 (2022); 96-101 ; 2413-5496 ; 2311-1267

    Περιγραφή αρχείου: application/pdf

    Relation: https://journal.nodgo.org/jour/article/view/888/785; Institute USD of HAHSNC, US Department of Health and Human Services; National Cancer Institute. Cancer Incidence and Survival among Children and Adolescents: United States SEER Program 1975–1995. PsycEXTRA Dataset, 1999. doi:10.1037/e407432005-001.; Cecchetto G., Bisogno G., Treuner J., Ferrari A., Mattke A., Casanova M., Dall’Igna P., Zanetti I., Volpato S., Siracusa F., Scarzello G., Boglino C., Carli M. Role of surgery for nonmetastatic abdominal rhabdomyosarcomas: a report from the Italian and German Soft Tissue Cooperative Groups Studies. Cancer. 2003; 97:1974–80. doi:10.1002/cncr.11285.; Kazi M., Qureshi S. S. Primary Peritoneal Rhabdomyosarcomatosis in a 2-Year-Old Child Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy – Case Report and Review of Literature. Indian J Surg Oncol. 2021; 12: 322–6. doi:10.1007/s13193-021-01351-3.; Rodríguez-Ortiz L., Arjona-Sánchez A., Ibañez-Rubio M., Sánchez-Hidalgo J., Casado-Adam A., Rufi án-Peña S., Briceño-Delgado J. Laparoscopic cytoreductive surgery and HIPEC: a comparative matched analysis. Surg Endosc. 2021; 35: 1778–85. doi:10.1007/s00464-020-07572-x.; Hayes-Jordan A., Green H., Lin H., Owusu-Agyemang P., Mejia R., Okhuysen-Cawley R., Cortes J., Fitzgerald N. E., McAleer M. F., Herzog C., Huh W. W., Anderson P. Cytoreductive surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for children, adolescents, and young adults: the fi rst 50 cases. Ann Surg Oncol. 2015; 22: 1726–32. doi:10.1245/s10434-014-4289-y.; Casey D. L., Wexler L. H., LaQuaglia M. P., Meyers P. A., Wolden S. L. Favorable outcomes after whole abdominopelvic radiation therapy for pediatric and young adult sarcoma. Pediatr Blood Cancer. 2014; 61: 1565–9. doi:10.1002/pbc.25088.; Kaseb H., Kuhn J., Babiker H. M. Rhabdomyosarcoma. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing, 2022. PMID: 29939543.; Lin C. N., Huang W. S., Huang T. H., Chen C. Y., Huang C. Y., Wang T. Y., Liao Y. S., Lee L. W. Adding Value of MRI over CT in Predicting Peritoneal Cancer Index and Completeness of Cytoreduction. Diagnostics (Basel). 2021; 11. doi:10.3390/diagnostics11040674.; Mercier F., Jeremie G., Alyami M., Delphine V., Vahan K., Pascal R., Sylvie I., Guillaume P., Olivier G. Long-term results of laparoscopic cytoreductive surgery and HIPEC for the curative treatment of low-grade pseudomyxoma peritonei and multicystic mesothelioma. Surg Endosc. 2020; 34: 4916–23. doi:10.1007/s00464-019-07280-1.; Arjona-Sanchez A., Esquivel J., Glehen O., Passot G., Turaga K. K., Labow D., Rufi an-Peña S., Morales R., van der Speeten K. A minimally invasive approach for peritonectomy procedures and hyperthermic intraperitoneal chemotherapy (HIPEC) in limited peritoneal carcinomatosis: The American Society of Peritoneal Surface Malignancies (ASPSM) multi-institution analysis. Surg Endosc. 2019; 33: 854–60. doi:10.1007/s00464-018-6352-4.; https://journal.nodgo.org/jour/article/view/888

  7. 7
  8. 8
  9. 9
    Academic Journal

    Πηγή: Сборник статей

    Περιγραφή αρχείου: application/pdf

    Relation: Актуальные вопросы современной медицинской науки и здравоохранения: сборник статей IV Международной научно-практической конференции молодых учёных и студентов, IV Всероссийского форума медицинских и фармацевтических вузов «За качественное образование», (Екатеринбург, 10-12 апреля 2019): в 3-х т. - Екатеринбург: УГМУ, CD-ROM.; http://elib.usma.ru/handle/usma/4005

    Διαθεσιμότητα: http://elib.usma.ru/handle/usma/4005

  10. 10
  11. 11
  12. 12
    Academic Journal

    Πηγή: Cancer Urology; Том 10, № 3 (2014); 78-82 ; Онкоурология; Том 10, № 3 (2014); 78-82 ; 1996-1812 ; 1726-9776 ; 10.17650/1726-9776-2017-21-8

    Περιγραφή αρχείου: application/pdf

    Relation: https://oncourology.abvpress.ru/oncur/article/view/384/400; Coleman J., Brennan M., Alektiar K., Russo P. Adult spermatic cord sarcomas: management and results. Ann Surg Oncol 2003;10: 669–75.; Katiku K., Esho J.O., Azodo M.V.U. Paratesticular Rhabdomyosarcoma in adolescents. Euro Urol 1988;14:245–8.; Stewart L.H., Lioc T.F., Johnston S.R. Thirty year of intra scrotal rhabdomyosarcoma. Br J Urol 1991;68:418–20.; Sygder II H.M., Dangio G.J., Evans A.E. et al. Pediatric oncology in Campbell’s urology, 7th ed., Philadelphia: WB Saunders, 1998.; Slama A., Jaidane M., Ben Sorba N. et al. Le rhabdomyosarcome paratesticulaire. Prog Urol 2000;10:1232–4.; McDowell H.P. Update on childhood rhabdomyosarcoma. Arch Dis Child 2003;88:354–7.; Newton W.A. Gehan E.A., Webber B.L. et al. Classification of rhabdomyosarcоmas and related sarcomas. Pathologic aspects and proposal for a new classification an Intergroup Rhabdomyosarcoma Study. Cancer 1995;76:1073–85.; Ferrari A., Casanova M., Massimino M. et al. The management of paratesticular rhabdomyosarcoma a single institutional experience with 44 consecutive children. J Urol 1998;159:1031–4.; Masson J.C., Varini J.P., Masson J. et al. Sarcomes du cordon spermatique: rapport de 2 cas. Revue de la litte´rature. Prog Urol 1992;2:272–81.; Olives D., Flamant F., Zucker J.M. et al. Paraaortic lymphadenectomy is not necessary in the treatment of localized paratesticular rhabdomyosarcoma. Cancer 1984;54:1283–7. 11. Anderson J.R., Ruby E., Link M. Identification of a favorable subset of patients with metastatic rhabdomyosarcoma. Proc Am Soc Clin Oncol 1997;16:abstr.; Meza J.L., Anderson J., Pappo A.S. et al. Analysis of prognostic factors in patients with nonmetastatic rhabdomyosarcoma treated on intergroup rhabdomyosarcoma studies III and IV: the children’s oncology group. J Clin Oncol 2006;24:3844–51.; Benson C.B., Doubilet P.M., Richie J.P. Sonography of the male genital tract. AJR 1989;153:705–13.; Stevens M.C., Rey A., Bouvet N. et al. Treatment of nonmetastatic rhabdomyosarcoma in childhood and adolescence: third study of the nternational society of paediatric oncology–SIOP malignant mesenchymal tumor 89. J Clin Oncol 2005;23: 2618–28.; Михайлова Е.В. Ультразвуковая диагностика опухолей яичка у детей. Автореф. дис. … канд. мед. наук. М., 2007.; Akbar S.A., Sayyed T.A., Jafri S.Z. et al. Multimodality imaging of paratesticular neoplasms and their rare mimics. Radiographics 2003;23:1461–76.; https://oncourology.abvpress.ru/oncur/article/view/384

  13. 13
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20